Evidence map›Paper›PMID 39351405›Full record

ArticleRSC advances2024

A logic-activated nanoswitch for killing cancer cells according to assessment of drug-resistance.

Lihua Zhang, Xiangxi Deng, Zhihe Qing, Yanli Lei, Feng Feng, Ronghua Yang, Zhen Zou

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in RSC advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Lihua ZhangCollege of Chemistry and Chemical Engineering, Shanxi Datong University Datong 037009 China feng-feng64@263.net.ORCID https://orcid.org/0000-0002-6589-3693
Xiangxi DengHunan Provincial Key Laboratory of Cytochemistry, School of Chemistry and Biological Engineering, Changsha University of Science and Technology Changsha 410004 China.
Zhihe QingHunan Provincial Key Laboratory of Cytochemistry, School of Chemistry and Biological Engineering, Changsha University of Science and Technology Changsha 410004 China.
Yanli LeiHunan Provincial Key Laboratory of Cytochemistry, School of Chemistry and Biological Engineering, Changsha University of Science and Technology Changsha 410004 China.ORCID https://orcid.org/0000-0003-4283-2254
Feng FengCollege of Chemistry and Chemical Engineering, Shanxi Datong University Datong 037009 China feng-feng64@263.net.ORCID https://orcid.org/0000-0002-0063-2724
Ronghua YangKey Laboratory of Chemical Biology & Traditional Chinese Medicine Research Ministry of Education, Institute of Interdisciplinary Studies, College of Chemistry and Chemical Engineering, Hunan Normal University Changsha 410081 China kobe474779970@126.com.ORCID https://orcid.org/0000-0001-7873-6892
Zhen ZouKey Laboratory of Chemical Biology & Traditional Chinese Medicine Research Ministry of Education, Institute of Interdisciplinary Studies, College of Chemistry and Chemical Engineering, Hunan Normal University Changsha 410081 China kobe474779970@126.com.ORCID https://orcid.org/0000-0001-7670-8951

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A logic-activated nanoswitch that could diagnose the differences between drug-resistant and non-drug-resistant cancer cells and control the release of drugs was developed for enhanced chemo-gene therapy using a standalone system. Compared to traditional treatments, the nanoswitch displayed improved anti-tumor efficiency

Identifiers

PMID39351405
PMCPMC11440625

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.